Tolnaftate Powder Spray - CVS Pharmacy

Manufacturer
CVS Pharmacy
Effective date
2026-04-01
Label type
HUMAN OTC DRUG LABEL
Version
11
Source
full-release
Hydrated at
2026-06-01 01:52:22

Label at a glance#

ProductTolnafate
Active ingredientTOLNAFTATE
Label structure10 sections

Indications and uses

cures most athlete's foot (tinea pedis), ringworm (tinea corporis) and jock itch (tinea cruris) can prevent recurrence of most athlete's foot relieves sypmtoms of athlete's foot, including itching, burning and cracking, and chafing associated with jock itch

Dosage and administration

wash affected area and dry thoroughly shake can well and spray a thin layer over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product to prevent athlete's foot, apply once or twice daily (morning and/or night) for athlete's foot, pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Tolnaftate 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • cures most athlete's foot (tinea pedis), ringworm (tinea corporis) and jock itch (tinea cruris)
  • can prevent recurrence of most athlete's foot
  • relieves sypmtoms of athlete's foot, including itching, burning and cracking, and chafing associated with jock itch

WARNINGS SECTION

For external use only.

Flammable:

SAFE HANDLING WARNING SECTION

Do not use while smoking or near heat or flame. Do not puncture or incinerate. Contents under pressure. Do not store at temperature above 120°F. Intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal.

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes or mouth
  • use only as directed

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • no improvement within 4 weeks for athlete's foot and ringworm; 2 weeks for jock itch
  • irritation occurs

Do not use

WARNINGS AND PRECAUTIONS SECTION

on children under 2 years of age unless directed by a doctor.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away. Do not use on children under 2 years of age unless directed by a doctor.

Directions

DOSAGE & ADMINISTRATION SECTION

  • wash affected area and dry thoroughly
  • shake can well and spray a thin layer over affected area twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product
  • to prevent athlete's foot, apply once or twice daily (morning and/or night)
  • for athlete's foot, pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily
  • use daily for 4 weeks for athlete's foot and ringworm; use daily for 2 weeks for jock itch
  • if condition persists, consult a doctor
  • this product is not effective on the scalp or nails
  • if nozzle clogs, clean with a pin

Other information

OTHER SAFETY INFORMATION

store between 20º and 30ºC (68º and 86ºF)

Inactive ingredients

INACTIVE INGREDIENT SECTION

BHT, isobutane, kaolin, PPG-12-buteth-16, SD alcohol 40-B, zea mays (corn) starch

Questions?

OTC - QUESTIONS SECTION

call 1-866-964-0939

RECENT MAJOR CHANGES SECTION

.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CVS Health

Antifungal

Athlete's Foot

Powder Spray

Tolnaftate 1%

  • Cures most athlete's foot
  • Relieves itching & burning
  • Talc free

NET WT 4.6 OZ (130g)

CARTONCARTON

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
705934tolnaftate 1 % Powder SprayPSN11
705934tolnaftate 0.01 MG/MG Powder SpraySCD11
705934tolnaftate 1 % Powder SpraySY11

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69842-512-46Tolnafate130 g in 1 CANAEROSOL, SPRAY13011

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69842-512-46GM - Gram69842-512ad47bd31-9b8a-4bef-be4d-2b7caf6ed78312021-07-15

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69842-51269842-512-46

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
102026-03-16monthly-update2026-06-03 17:58:51
92025-10-29monthly-update2026-06-03 17:39:38
82024-11-08full-release2026-06-01 00:35:53

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TolnafateTOLNAFTATE POWDER SPRAYCVS Pharmacya7b6bd7c-23db-43e1-92f7-e27f5f4801de2026-04-01WarningsExact identifier
ndc (package): 69842-512-46
ndc (product): 69842-512
ndc11 (package): 69842051246
spl id: 4e68421f-fa58-be3f-e063-6394a90acc93
spl set id: a7b6bd7c-23db-43e1-92f7-e27f5f4801de

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.